Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

How researchers are revamping antimicrobial drugs

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature 586, S55-S56 (2020)


This article is part of Nature Outlook: Antimicrobial resistance, an editorially independent supplement produced with the financial support of third parties. About this content.

Updates & Corrections

  • Clarification 14 January 2021: The caption for the image showing Kim Lewis has been amended to also name postdoc Yu Imai.


  1. Du, D. et al. Nature Rev. Microbiol. 16, 523–539 (2018).

    Article  PubMed  Google Scholar 

  2. Marshall, R. L. et al. mBio (2020).

    Article  Google Scholar 

  3. Imai, Y. et al. Nature 576, 459–464 (2019).

    Article  PubMed  Google Scholar 

  4. Ling, L. L. et al. Nature 517, 455–459 (2015).

    Article  PubMed  Google Scholar 

  5. Smith, T. C. et al. Proc. Natl Acad. Sci. 117, 18744–18753 (2020).

    Article  PubMed  Google Scholar 

Download references


Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links